News

Coronavirus

03 November 2021

ReiThera Awarded Grant to Develop Next Generation Vaccines

Program funded by the Bill & Melinda Gates Foundation will use ReiThera’s GRAd platform technology to develop next generation vaccines against SARS-CoV-2 emerging variants and HIV

21 September 2021

3rd edition of the HealthTech Innovation Days - 4 & 5 October in Paris

Several speakers will share their views during the scheduled round-tables

07 September 2021

Newron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB)

Tranche 4 consists of EUR 7.5 million and will primarily be used to support the Company’s development programs in diseases of the central nervous system.

18 July 2021

Axxam announces the launch of Muna Therapeutics ApS with EUR 60 Million to advance novel small molecule therapeutics for neurodegenerative diseases

Axxam is proud to announce that Muna Therapeutics, a biotech company founded in 2020 by Aarhus University, financed by Novo Seeds and receiving assets in exchange of equity from Axxam, was successful closing a EUR 60 million (US$ 73 million) Series A financing round

12 July 2021

EryDel Announces Top-line Results from Phase3 ATTeST Trial Demonstrating Significant Clinical Benefit of EryDex in Ataxia Telangiectasia

EryDel SpA announced topline results from its Phase 3 ATTeST clinical trial in patients with Ataxia Telangiectasia (AT), a devastating neurological disease for which there is no approved therapy

05 July 2021

HealthTech For Care and EIT Health publish the agenda of the 3rd edition of the HealthTech Innovation Days event next 4 & 5 October 2021

Federchimica Assobiotec is one of the partner of this 3rd edition of the HealthTech Innovation Days (HTID®), placed under the High Patronage of Emmanuel Macron, President of the French Republic. The European healthcare ecosystem will gather around tomorrow's health major challenges: Artificial Intelligence, health data regulation, impact of the Covid-19 crisis and antibiotic resistance or robotics. The HTID mobilises both international sponsors and European clusters.

1 2 3 4 5 ...

20149 Milan
Via Giovanni da Procida, 11
Show map

Tel. +39 02.34565.1
Fax. +39 02.34565.310

Segreteria Assobiotec
Tel. 02 34565.256/341
assobiotec@federchimica.it